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Background: The Ross procedure is used to treat aortic valve disease in children with advantages including potential for autograph growth, long-
term durability, and avoidance of anticoagulation. Long-term follow up of the Ross procedure in infancy is limited. The purpose of this study was to 
report long-term follow up of infants undergoing the Ross procedure.
Methods: We performed a retrospective review of all patients who underwent a Ross operation at less than 18 months of age at New-York 
Presbyterian and Cardiothoracic Center of Monaco between May, 1991 and June, 2010. Clinical, catheterization, and surgical records were reviewed. 
The most recent echocardiogram was reviewed by a single examiner to measure autograft insufficiency (AI), autograft dimensions, and homograft 
function.
Results: 32 patients underwent a Ross at a median age of 5.8 mo (range 4 d-17.2 mo). All had congenital aortic stenosis (AS). Associated lesions 
included sub-AS (n=11), supravalvar AS (n=3), coarctation (n=5) and interrupted aortic arch (IAA, n=2). All but 1 patient had prior interventions: 
catheter based balloon valvuloplasty (n=18), surgical valvotomy (n=9) or repair of an associated surgical lesion (coarctation, IAA) (n=10). Median 
follow up was 9.5 yrs (range 1.4-20.4). There were 4 early deaths; 1 patient underwent a transplant 15 yrs post-surgery. Freedom from homograft 
reintervention was 87% at 5 yrs and 62% at 10 yrs. Of the 12 homograft reinterventions, 6 were surgical and 6 were catheter based; 2 patients 
required a second homograft procedure. Freedom from autograft reintervention was 95% at 10 yrs; only 1 patient required reintervention 5.7 yrs 
post-Ross. Late follow-up echocardiograms were available in 20 subjects. There was a significant difference between mean early and late z scores 
of autograft annulus (0.8 vs 2.4, p=.03), sinus (0.8 vs 2.8, p=.002) and sino-tubular junction (1.2 vs 2.7, p=.04). Mild or less AI occurred in 17 
subjects; 1 had mild-moderate and 2 had moderate AI. None had significant AS.
Conclusions: Long-term outcomes of the Ross procedure in infants are favorable despite moderate dilatation of the autograft. Reintervention at 
the homograft is common.
